placeholder image
M. Reck All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. 
    New England Journal of Medicine. 2018
  • Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. 
    New England Journal of Medicine. 2018
    • Contact
    full name
  • M. Reck
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration